{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:04:47Z","timestamp":1793498687913,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.berh.2022.101766","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T08:08:04Z","timestamp":1660032484000},"page":"101766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Male osteoporosis-what are the causes, diagnostic challenges, and management"],"prefix":"10.1016","volume":"36","author":[{"given":"Sigridur","family":"Bj\u00f6rnsdottir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart L.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mannstadt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente L.","family":"Langdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.berh.2022.101766_bib1","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","article-title":"An estimate of the worldwide prevalence and disability associated with osteoporotic fractures","volume":"17","author":"Johnell","year":"2006","journal-title":"Osteoporos Int"},{"issue":"6","key":"10.1016\/j.berh.2022.101766_bib2","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.bone.2004.11.015","article-title":"Varying contributions of growth and ageing to racial and sex differences in femoral neck structure and strength in old age","volume":"36","author":"Wang","year":"2005","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.berh.2022.101766_bib3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.061113","article-title":"Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025","volume":"22","author":"Burge","year":"2007","journal-title":"J\u00a0Bone Miner Res"},{"issue":"12","key":"10.1016\/j.berh.2022.101766_bib4","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.2105\/AJPH.74.12.1374","article-title":"Race and sex differences in hip fracture incidence","volume":"74","author":"Farmer","year":"1984","journal-title":"Am J Publ Health"},{"issue":"5","key":"10.1016\/j.berh.2022.101766_bib5","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/acr.21580","article-title":"Hip fractures in the United States: 2008 nationwide emergency department sample","volume":"64","author":"Kim","year":"2012","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.berh.2022.101766_bib6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/ageing\/afr114","article-title":"Incidence rates of fragility hip fracture in middle-aged and elderly men and women in southern Norway","volume":"41","author":"Diamantopoulos","year":"2012","journal-title":"Age Ageing"},{"issue":"3","key":"10.1016\/j.berh.2022.101766_bib7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/oxfordjournals.aje.a008920","article-title":"Risk factors for osteoporotic fractures in elderly men","volume":"144","author":"Nguyen","year":"1996","journal-title":"Am J Epidemiol"},{"issue":"19","key":"10.1016\/j.berh.2022.101766_bib8","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/archinte.162.19.2217","article-title":"Undertreatment of osteoporosis in men with hip fracture","volume":"162","author":"Kiebzak","year":"2002","journal-title":"Arch Intern Med"},{"issue":"18","key":"10.1016\/j.berh.2022.101766_bib9","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1001\/archinte.163.18.2165","article-title":"Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures: a gap in evidence-based practice guideline implementation","volume":"163","author":"Feldstein","year":"2003","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.berh.2022.101766_bib10","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1532-5415.2011.03399.x","article-title":"Hip fracture in men-survival and subsequent fractures: a cohort study with 22-year follow-up","volume":"59","author":"von Friesendorff","year":"2011","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"6","key":"10.1016\/j.berh.2022.101766_bib11","doi-asserted-by":"crossref","first-page":"380","DOI":"10.7326\/0003-4819-152-6-201003160-00008","article-title":"Meta-analysis: excess mortality after hip fracture among older women and men","volume":"152","author":"Haentjens","year":"2010","journal-title":"Ann Intern Med"},{"issue":"9156","key":"10.1016\/j.berh.2022.101766_bib12","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(98)09075-8","article-title":"Mortality after all major types of osteoporotic fracture in men and women: an observational study","volume":"353","author":"Center","year":"1999","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.berh.2022.101766_bib13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/jama.2009.50","article-title":"Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women","volume":"301","author":"Bliuc","year":"2009","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.berh.2022.101766_bib14","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1359\/jbmr.2003.18.12.2231","article-title":"Gender differences in mortality after hip fracture: the role of infection","volume":"18","author":"Wehren","year":"2003","journal-title":"J\u00a0Bone Miner Res"},{"issue":"5","key":"10.1016\/j.berh.2022.101766_bib15","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.beem.2018.05.007","article-title":"Update on osteoporosis in men","volume":"32","author":"Adler","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"issue":"2","key":"10.1016\/j.berh.2022.101766_bib16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ecl.2021.03.001","article-title":"Updates on osteoporosis in men","volume":"50","author":"Diab","year":"2021","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"2","key":"10.1016\/j.berh.2022.101766_bib17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1359\/jbmr.071020","article-title":"A\u00a0population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men","volume":"23","author":"Riggs","year":"2008","journal-title":"J\u00a0Bone Miner Res"},{"issue":"6","key":"10.1016\/j.berh.2022.101766_bib18","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0002-9343(83)90878-1","article-title":"Risk factors for spinal osteoporosis in men","volume":"75","author":"Seeman","year":"1983","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.berh.2022.101766_bib19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1210\/edrv-16-1-87","article-title":"Osteoporosis in men","volume":"16","author":"Orwoll","year":"1995","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1016\/j.berh.2022.101766_bib20","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1210\/er.2008-0002","article-title":"Osteoporosis in men","volume":"29","author":"Khosla","year":"2008","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.berh.2022.101766_bib21","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ecl.2012.05.001","article-title":"Male osteoporosis","volume":"41","author":"Drake","year":"2012","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"3","key":"10.1016\/j.berh.2022.101766_bib22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1210\/jcem-69-3-523","article-title":"Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling","volume":"69","author":"Stepan","year":"1989","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.berh.2022.101766_bib23","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/1097-0142(20010615)91:12<2238::AID-CNCR1254>3.0.CO;2-2","article-title":"Low bone mineral density in hormone-naive men with prostate carcinoma","volume":"91","author":"Smith","year":"2001","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.berh.2022.101766_bib24","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1002\/cncr.10967","article-title":"Low bone density and high percentage of body fat among men who were treated with androgen deprivation therapy for prostate carcinoma","volume":"95","author":"Chen","year":"2002","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.berh.2022.101766_bib25","first-page":"1952","article-title":"Osteoporosis in men treated with androgen deprivation therapy for prostate cancer","volume":"167","author":"Ross","year":"2002","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.berh.2022.101766_bib26","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMoa041943","article-title":"Risk of fracture after androgen deprivation for prostate cancer","volume":"352","author":"Shahinian","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.berh.2022.101766_bib27","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1359\/jbmr.1999.14.7.1061","article-title":"New developments in the pathogenesis and treatment of steroid-induced osteoporosis","volume":"14","author":"Manolagas","year":"1999","journal-title":"J\u00a0Bone Miner Res"},{"issue":"3","key":"10.1016\/j.berh.2022.101766_bib28","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0169-6009(89)90012-3","article-title":"Spinal osteoporosis in men","volume":"5","author":"Francis","year":"1989","journal-title":"Bone Miner"},{"issue":"3","key":"10.1016\/j.berh.2022.101766_bib29","doi-asserted-by":"crossref","first-page":"138","DOI":"10.5694\/j.1326-5377.1998.tb116014.x","article-title":"Hip fracture in elderly men: the importance of subclinical vitamin D deficiency and hypogonadism","volume":"169","author":"Diamond","year":"1998","journal-title":"Med J Aust"},{"issue":"6","key":"10.1016\/j.berh.2022.101766_bib30","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1210\/jc.2006-1525","article-title":"Vitamin D status predicts physical performance and its decline in older persons","volume":"92","author":"Wicherts","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.berh.2022.101766_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/ajcn\/88.2.513S","article-title":"Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health","volume":"88","author":"Cranney","year":"2008","journal-title":"Am J Clin Nutr"},{"issue":"12","key":"10.1016\/j.berh.2022.101766_bib32","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1359\/jbmr.040916","article-title":"Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites","volume":"19","author":"Riggs","year":"2004","journal-title":"J\u00a0Bone Miner Res"},{"issue":"1","key":"10.1016\/j.berh.2022.101766_bib33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bone.2003.10.001","article-title":"Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study","volume":"34","author":"Schuit","year":"2004","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.berh.2022.101766_bib34","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jocd.2019.07.001","article-title":"Executive summary of the 2019 ISCD position development conference on monitoring treatment, DXA cross-calibration and least significant change, spinal cord injury, peri-prosthetic and orthopedic bone health, transgender medicine, and pediatrics","volume":"22","author":"Shuhart","year":"2019","journal-title":"J\u00a0Clin Densitom"},{"issue":"1","key":"10.1016\/j.berh.2022.101766_bib35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jocd.2006.05.004","article-title":"Application of the 1994 WHO classification to populations other than postmenopausal Caucasian women: the 2005 ISCD Official Positions","volume":"9","author":"Leslie","year":"2006","journal-title":"J\u00a0Clin Densitom"},{"issue":"3","key":"10.1016\/j.berh.2022.101766_bib37","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00198-010-1524-7","article-title":"Guidance for the adjustment of FRAX according to the dose of glucocorticoids","volume":"22","author":"Kanis","year":"2011","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.berh.2022.101766_bib38","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4158\/EP12059.RA","article-title":"Secondary causes of osteoporosis","volume":"19","author":"Hudec","year":"2013","journal-title":"Endocr Pract"},{"key":"10.1016\/j.berh.2022.101766_bib39","article-title":"The impact of multifaceted osteoporosis group education on patients' decision-making regarding treatment options and lifestyle changes","volume":"2018","author":"Jensen","year":"2018","journal-title":"J\u00a0Osteoporos"},{"issue":"9","key":"10.1016\/j.berh.2022.101766_bib40","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1056\/NEJM200008313430902","article-title":"Alendronate for the treatment of osteoporosis in men","volume":"343","author":"Orwoll","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.berh.2022.101766_bib41","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1359\/jbmr.081214","article-title":"Once-weekly risedronate in men with osteoporosis: results of a 2-year, placebo-controlled, double-blind, multicenter study","volume":"24","author":"Boonen","year":"2009","journal-title":"J\u00a0Bone Miner Res"},{"issue":"18","key":"10.1016\/j.berh.2022.101766_bib42","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1056\/NEJMoa1204061","article-title":"Fracture risk and zoledronic acid therapy in men with osteoporosis","volume":"367","author":"Boonen","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.berh.2022.101766_bib43","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1210\/jc.2012-1569","article-title":"A\u00a0randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral density","volume":"97","author":"Orwoll","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.berh.2022.101766_bib44","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1210\/jc.2014-4079","article-title":"A\u00a024-month study evaluating the efficacy and safety of denosumab for the treatment of men with low bone mineral density: results from the ADAMO trial","volume":"100","author":"Langdahl","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.berh.2022.101766_bib45","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJMoa0809003","article-title":"Denosumab in men receiving androgen-deprivation therapy for prostate cancer","volume":"361","author":"Smith","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.berh.2022.101766_bib46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1359\/jbmr.2003.18.1.9","article-title":"The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis","volume":"18","author":"Orwoll","year":"2003","journal-title":"J\u00a0Bone Miner Res"},{"issue":"12","key":"10.1016\/j.berh.2022.101766_bib47","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1007\/s00198-009-0917-y","article-title":"Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status","volume":"20","author":"Langdahl","year":"2009","journal-title":"Osteoporos Int"},{"issue":"9","key":"10.1016\/j.berh.2022.101766_bib48","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1210\/jc.2017-02163","article-title":"A\u00a0phase III randomized placebo-controlled trial to evaluate efficacy and safety of romosozumab in men with osteoporosis","volume":"103","author":"Lewiecki","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.berh.2022.101766_bib49","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jamainternmed.2016.9539","article-title":"Effect of testosterone treatment on volumetric bone density and strength in older men with low testosterone: a controlled clinical trial","volume":"177","author":"Snyder","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.berh.2022.101766_bib50","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/jbmr.3051","article-title":"Treatment sequence matters: anabolic and antiresorptive therapy for osteoporosis","volume":"32","author":"Cosman","year":"2017","journal-title":"J\u00a0Bone Miner Res"},{"issue":"1","key":"10.1016\/j.berh.2022.101766_bib51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jbmr.4433","article-title":"Validation of the surrogate threshold effect for change in bone mineral density as a surrogate endpoint for fracture outcomes: the FNIH-asbmr SABRE project","volume":"37","author":"Eastell","year":"2022","journal-title":"J\u00a0Bone Miner Res"},{"issue":"6","key":"10.1016\/j.berh.2022.101766_bib52","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/jbmr.3722","article-title":"Relationship between bone mineral density T-score and nonvertebral fracture risk over 10 Years of denosumab treatment","volume":"34","author":"Ferrari","year":"2019","journal-title":"J\u00a0Bone Miner Res"},{"issue":"6","key":"10.1016\/j.berh.2022.101766_bib53","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1210\/jc.2011-3045","article-title":"Osteoporosis in men: an Endocrine Society clinical practice guideline","volume":"97","author":"Watts","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.berh.2022.101766_bib54","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician's guide to prevention and treatment of osteoporosis","volume":"25","author":"Cosman","year":"2014","journal-title":"Osteoporos Int"},{"issue":"24","key":"10.1016\/j.berh.2022.101766_bib55","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1001\/jama.2018.7498","article-title":"Screening for osteoporosis to prevent fractures: US preventive Services Task Force recommendation statement","volume":"319","author":"Uspst","year":"2018","journal-title":"JAMA"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694222000250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694222000250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:22:43Z","timestamp":1761499363000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694222000250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1521694222000250"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2022.101766","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Male osteoporosis-what are the causes, diagnostic challenges, and management","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2022.101766","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101766"}}